Patents by Inventor Michael Benatar

Michael Benatar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230176078
    Abstract: The disclosure provides a method of predicting the onset of clinical manifestations of amyotrophic lateral sclerosis (ALS) in a human, the method comprising (a) measuring phosphorylated neurofilament heavy chain (pNfH) and/or neurofilament light chain (NfL) levels in a subject, and (b) predicting the onset of ALS, wherein increased levels of pNfH and/or NfL signal the onset of clinical manifestations of ALS.
    Type: Application
    Filed: September 9, 2022
    Publication date: June 8, 2023
    Inventors: Michael Benatar, Andrea Malaspina
  • Publication number: 20210172963
    Abstract: The disclosure provides a method of predicting the onset of clinical manifestations of amyotrophic lateral sclerosis (ALS) in a human, the method comprising (a) measuring phosphorylated neurofilament heavy chain (pNfH) and/or neurofilament light chain (NfL) levels in a subject, and (b) predicting the onset of ALS, wherein increased levels of pNfH and/or NfL signal the onset of clinical manifestations of ALS.
    Type: Application
    Filed: May 25, 2018
    Publication date: June 10, 2021
    Inventors: Michael Benatar, Andrea Malaspina
  • Publication number: 20190175577
    Abstract: The disclosure provides a method of treating amyotrophic lateral sclerosis (ALS) in a subject in need thereof, the method comprising administering to the subject a daily dose of Arimoclomol exceeding 300 mg per day.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 13, 2019
    Inventor: Michael Benatar